FONDAPARINUX IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION – JUSTIFICATION FOR USING AND REAL CLINICAL PRACTICE
Prevention of activation of blood coagulation is a cornerstone of treatment strategies in patients with acute coronary syndrome (ACS). Medications that are used for this purpose help stop building up of blood clots in the area of damaged atherosclerotic plaque and prevent the development or recurren...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | مقال |
| اللغة: | Russian |
| منشور في: |
«REMEDIUM GROUP» Ltd.
2018-05-01
|
| سلاسل: | Атеротромбоз |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.aterotromboz.ru/jour/article/view/147 |